Reduction of nocturnal rise in bone resorption by subcutaneous GLP-2

Bone

Volumn 34, Issue 1, 2004, Pages 140-147

  Henriksen, Dennis B ^a   Alexandersen, Peter ^b   Byrjalsen, Inger ^a   Hartmann, Bolette ^c   Bone, Henry G ^d   Christiansen, Claus ^b   Holst, Jens Juul ^c  

^a NORDIC BIOSCIENCE A S   (Denmark)

^b CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d Michigan Bone and Mineral Clinic   (United States)

Author keywords

Bone formation; Bone resorption; Bone turnover markers; Glucagon like peptide 2; Osteocalcin

Indexed keywords

GLUCAGON LIKE PEPTIDE 2; OSTEOCALCIN;

ADULT; ARTICLE; BONE TURNOVER; CARBOXY TERMINAL SEQUENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; NORMAL HUMAN; OSSIFICATION; OSTEOLYSIS; POSTMENOPAUSE;

EID: 0942278946     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2003.09.009     Document Type: Article

References (23)

1. Aoshima H., Kushida K., Takahashi M., Ohishi T., Hoshino H., Suzuki M.et al. Circadian variation of urinary type I collagen crosslinked C-telopeptide and free and peptide-bound forms of pyridinium crosslinks. Bone. 22:1998;73-78.
2. Bjarnason N.H., Henriksen E.E., Alexandersen P., Christgau S., Henriksen D.B., Christiansen C. Mechanism of circadian variation in bone resorption. Bone. 30:2002;307-313.
3. Burr D.B. Targeted and nontargeted remodeling. Bone. 30:2002;2-4.
4. Burrin D.G., Petersen Y., Stoll B., Sangild P. Glucagon-like peptide 2: a nutrient-responsive gut growth factor. J. Nutr. 131:2001;709-712.
5. Caillot-Augusseau A., Vico L., Heer M., Voroviev D., Souberbielle J.C., Zitterman A.et al. Space flight is associated with rapid decreases of undercarboxylated osteocalcin and increases of markers of bone resorption without changes in their circadian variation: observations in two cosmonauts. Clin. Chem. 46:2000;1136-1143.
6. Christgau S., Bitsch-Jensen O., Bjarnason N.H., Henriksen E.G., Qvist P., Alexandersen P.et al. Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy. Bone. 26:2000;505-511.
7. Clowes J.A., Hannon R.A., Yap T.S., Hoyle N.R., Blumsohn A., Eastell R. Effect of feeding on bone turnover markers and its impact on biological variability of measurements. Bone. 30:2002;886-890.
8. Clowes J.A., Robinson R.T., Heller S.R., Eastell R., Blumsohn A. Acute changes of bone turnover and PTH induced by insulin and glucose: euglycemic and hypoglycemic hyperinsulinemic clamp studies. J. Clin. Endocrinol. Metab. 87:2002;3324-3329.
9. Drucker D.J. Biological actions and therapeutic potential of the glucagon-like peptides. Gastroenterology. 122:2002;531-544.
10. Hartmann B., Johnsen A.H., Orskov C., Adelhorst K., Thim L., Holst J.J. Structure, measurement, and secretion of human glucagon-like peptide-2. Peptides. 21:2000;73-80.
11. Henriksen DB, Alexandersen P, Bjarnason NH, Vilsboll T, Hartmann B, Henriksen EG, et al. Role of Gastrointestinal Hormones in Postprandial Reduction of Bone Resorption. J Bone Miner Res [in press].
12. Heshmati H.M., Riggs B.L., Burritt M.F., McAlister C.A., Wollan P.C., Khosla S. Effects of the circadian variation in serum cortisol on markers of bone turnover and calcium homeostasis in normal postmenopausal women. J. Clin. Endocrinol. Metab. 83:1998;751-756.
13. Holst J.J. Gut hormones as pharmaceuticals. From enteroglucagon to GLP-1 and GLP-2. Regul. Pept. 93:2000;45-51.
14. Lakatos P., Blumsohn A., Eastell R., Tarjan G., Shinoda H., Stern P.H. Circadian rhythm of in vitro bone-resorbing activity in human serum. J. Clin. Endocrinol. Metab. 80:1995;3185-3190.
15. Ledger G.A., Burritt M.F., Kao P.C., O'Fallon W.M., Riggs B.L., Khosla S. Role of parathyroid hormone in mediating nocturnal and age-related increases in bone resorption. J. Clin. Endocrinol. Metab. 80:1995;3304-3310.
16. Ostrowska Z., Kos-Kudla B., Swietochowska E., Marek B., Kajdaniuk D., Gorski J. Assessment of the relationship between dynamic pattern of nighttime levels of melatonin and chosen biochemical markers of bone metabolism in a rat model of postmenopausal osteoporosis. Neuroendocrinol. Lett. 22:2001;129-136.
17. Parfitt A.M. Targeted and nontargeted bone remodeling: relationship to basic multicellular unit origination and progression. Bone. 30:2002;5-7.
18. Reiter R.J. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr. Rev. 12:1991;151-180.
19. Schlemmer A., Hassager C. Acute fasting diminishes the circadian rhythm of biochemical markers of bone resorption. Eur. J. Endocrinol. 140:1999;332-337.
20. Schlemmer A., Hassager C., Alexandersen P., Fledelius C., Pedersen B.J., Kristensen I.O.et al. Circadian variation in bone resorption is not related to serum cortisol. Bone. 21:1997;83-88.
21. Schlemmer A., Hassager C., Pedersen B.J., Christiansen C. Posture, age, menopause, and osteopenia do not influence the circadian variation in the urinary excretion of pyridinium crosslinks. J. Bone Miner. Res. 9:1994;1883-1888.
22. Wichers M., Schmidt E., Bidlingmaier F., Klingmuller D. Diurnal rhythm of CrossLaps in human serum. Clin. Chem. 45:1999;1858-1860.
23. Wojdemann M., Wettergren A., Hartmann B., Holst J.J. Glucagon-like peptide-2 inhibits centrally induced antral motility in pigs. Scand. J. Gastroenterol. 33:1998;828-832.